Aurora kinase A (also called STK15 and BTAK) is overexpressed in many human
cancers. Ectopic overexpression of
aurora kinase A in mammalian cells induces centrosome amplification,
chromosome instability and oncogenic transformation, a phenotype characteristic of loss-of-function mutations of p53. Here we show that
aurora kinase A phosphorylates p53 at Ser315, leading to its ubiquitination by Mdm2 and proteolysis. p53 is not degraded in the presence of inactive
aurora kinase A or ubiquitination-defective Mdm2. Destabilization of p53 by
aurora kinase A is abrogated in the presence of mutant Mdm2 that is unable to bind p53 and after repression of Mdm2 by RNA interference. Silencing of
aurora kinase A results in less phosphorylation of p53 at Ser315, greater stability of p53 and cell-cycle arrest at G2-M. Cells depleted of
aurora kinase A are more sensitive to
cisplatin-induced apoptosis, and elevated expression of
aurora kinase A abolishes this response. In a sample of
bladder tumors with wild-type p53, elevated expression of
aurora kinase A was correlated with low p53 concentration. We conclude that
aurora kinase A is a key regulatory component of the p53 pathway and that overexpression of
aurora kinase A leads to increased degradation of p53, causing downregulation of checkpoint-response pathways and facilitating oncogenic transformation of cells.